e-learning
resources
London 2016
Sunday, 04.09.2016
Highlights in the management of COPD and beyond
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC Abstract – Potential use of β-blockers to reduce COPD exacerbations
Lies Lahousse (Ghent, Belgium), Lies Lahousse, Phebe De Nocker, Albert Hofman, Bruno Stricker, Guy Brusselle, Katia Verhamme
Source:
International Congress 2016 – Highlights in the management of COPD and beyond
Session:
Highlights in the management of COPD and beyond
Session type:
Oral Presentation
Number:
1502
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lies Lahousse (Ghent, Belgium), Lies Lahousse, Phebe De Nocker, Albert Hofman, Bruno Stricker, Guy Brusselle, Katia Verhamme. LSC Abstract – Potential use of β-blockers to reduce COPD exacerbations. Eur Respir J 2016; 48: Suppl. 60, 1502
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Modelling exacerbations of COPD
Source: Annual Congress 2012 - Modelling respiratory infections: is it the future or the present?
Year: 2012
Evaluation of COPD exacerbations using the EXACT-U
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
COPD exacerbations: Causes and consequences
Source: ERS Live 2007
Year: 2007
Causes and management of exacerbations of COPD
Source: ISSN=ISSN 1810-6838, ISBN=, page=250
Year: 2007
Measuring and quantifying acute exacerbations of COPD: pitfalls and practicalities
Source: Eur Respir J 2014; 43: 662-664
Year: 2014
Impact of halotherapy on COPD exacerbations
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
LSC Abstract – Bacterial burden in rhinovirus-induced asthma exacerbations
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Therapeutic options for COPD exacerbations
Source: International Congress 2014 – PG04 Update on COPD exacerbations
Year: 2014
Predictors of exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005
Methodologies for study of COPD exacerbations
Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview
Year: 2012
The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014
Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Management of COPD exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019
COPD exacerbations: impact and prevention
Source: Breathe 2013; 9: 434-440
Year: 2013
Potential usefulness of phenotyping in asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
Impact of frequent exacerbations in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014
Phenotype-based therapy of COPD: Effect on the rate of COPD exacerbations
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Assessment of malondialdehyde in the airways during treatment of COPD exacerbations
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Mathematical model to predict the risk of future exacerbations in non-smoking patients with COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept